Emmes is a global full service clinical research organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation. Founded in 1977, Emmes has conducted over 2000 clinical studies across a broad range of therapeutic areas, with significant expertise in infectious diseases, vaccines, ophthalmology, oncology, neurology, substance use disorders, and maternal and child health.